Latest News and Press Releases

G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting

G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit

G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib

G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024

G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)